Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

NEU PEER ANALYSIS

NewMarket Corporation — metric-by-metric comparison with peers and the industry median

NEUNewMarket Corporation

🇺🇸 USA · NYSE · Basic Materials · Specialty Chemicals

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Specialty Chemicals

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
NEUIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
NEU+9.6%ORI+23.3%BNR+4.7%IMCD-25.3%DNL+43.2%AKZA+3.6%
Year-to-Date (YTD)
NEU+16.8%ORI-1.2%BNR+16.6%IMCD+9.0%DNL+20.1%AKZA+4.2%
1-Year
Split-adjusted
NEU+9.6%AXTA+13.4%EMN-6.6%WLK-0.5%PRM+118.7%BCPC+4.1%
Year-to-Date (YTD)
NEU+16.8%AXTA+6.0%EMN+11.6%WLK+4.3%PRM+21.5%BCPC+9.6%

Key Metric Comparison

P/E

Lower is better
NEU18.25ORI44.06BNR35.37IMCD22.50DNL—AKZA16.51Median 27.59

ROE

Higher is better
NEU25.3%ORI6.1%BNR5.0%IMCD10.2%DNL3.8%AKZA13.1%Median 4.4%

Net Margin

Higher is better
NEU15.3%ORI3.1%BNR1.5%IMCD4.5%DNL4.5%AKZA6.3%Median 3.5%

Revenue Growth

Higher is better
NEU-3.5%ORI1.8%BNR-9.5%IMCD1.2%DNL-16.6%AKZA-7.0%Median 1.2%

P/E

Lower is better
NEU18.25AXTA19.92EMN20.05WLK—PRM—BCPC34.33Median 27.59

ROE

Higher is better
NEU25.3%AXTA16.4%EMN6.7%WLK-17.3%PRM-15.7%BCPC12.7%Median 4.4%

Net Margin

Higher is better
NEU15.3%AXTA7.2%EMN4.6%WLK-14.9%PRM-26.9%BCPC15.0%Median 3.5%

Revenue Growth

Higher is better
NEU-3.5%AXTA-2.6%EMN-7.7%WLK-8.6%PRM23.0%BCPC9.6%Median 1.2%

All Metrics

Valuation
MetricNEUORIBNRIMCDDNLAKZAInd. Median
P/E18.2544.0635.3722.50—16.51●27.59
P/B4.322.961.802.401.70●2.101.79
EV/EBITDA11.859.689.2512.2112.468.38●12.38
P/S2.781.370.55●1.021.841.031.67
Financial Health
MetricNEUORIBNRIMCDDNLAKZAInd. Median
Current Ratio2.55●1.311.741.731.271.721.87
Debt/Equity58.9%86.9%75.4%83.4%39.7%●125.2%63.0%
NetDebt/EBITDA1.33●1.772.312.812.151.942.15
Profitability
MetricNEUORIBNRIMCDDNLAKZAInd. Median
Net Margin15.3%●3.1%1.5%4.5%4.5%6.3%3.5%
ROE25.3%●6.1%5.0%10.2%3.8%13.1%4.4%
ROA12.2%●2.5%2.0%4.6%2.2%4.1%2.0%
EBITDA Margin26.4%●17.3%7.9%10.9%17.8%16.0%14.7%
Growth + Dividend
MetricNEUORIBNRIMCDDNLAKZAInd. Median
Rev. Growth-3.5%1.8%●-9.5%1.2%-16.6%-7.0%1.2%
NI Growth-14.5%155.6%●-56.9%-21.8%—32.7%-4.8%
Div. Yield1.5%2.5%3.4%2.2%3.6%●3.3%1.5%
Payout26.2%107.9%132.9%58.4%126.7%56.0%9.1%
Valuation
MetricNEUAXTAEMNWLKPRMBCPCInd. Median
P/E18.25●19.9220.05——34.3327.59
P/B4.323.041.331.14●4.584.221.79
EV/EBITDA11.859.84●10.71——20.4712.38
P/S2.781.440.930.89●7.825.131.67
Financial Health
MetricNEUAXTAEMNWLKPRMBCPCInd. Median
Current Ratio2.552.101.472.173.09●2.551.87
Debt/Equity58.9%130.0%88.6%75.1%113.4%14.4%●63.0%
NetDebt/EBITDA1.332.533.94-8.78-9.65●0.412.15
Profitability
MetricNEUAXTAEMNWLKPRMBCPCInd. Median
Net Margin15.3%●7.2%4.6%-14.9%-26.9%15.0%3.5%
ROE25.3%●16.4%6.7%-17.3%-15.7%12.7%4.4%
ROA12.2%●4.9%2.6%-8.1%-6.8%9.5%2.0%
EBITDA Margin26.4%●19.7%13.7%-4.1%-18.7%25.6%14.7%
Growth + Dividend
MetricNEUAXTAEMNWLKPRMBCPCInd. Median
Rev. Growth-3.5%-2.6%-7.7%-8.6%23.0%●9.6%1.2%
NI Growth-14.5%-17.8%-56.7%——15.8%●-4.8%
Div. Yield1.5%0.0%5.0%●2.9%—0.6%1.5%
Payout26.2%0.0%95.5%-16.6%—19.5%9.1%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on NEU

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.